Impact of smoking on health‐related quality‐of‐life outcomes in prostate cancer survivors
Cancer · 01.03.2026 · 132 (5)
DOI: 10.1002/cncr.70336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 03.03.2026. Verfasst von Benjamin Borgert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Quality of Life, Prostatic Neoplasms, Smoking, Cancer Survivors. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute, AHRQ HHS.
Abstract (Originalsprache)
Background
Smoking may negatively affect health‐related quality of life (HRQOL) in prostate cancer survivors, even though it is not a smoking‐related malignancy. The longitudinal association of smoking with HRQOL was evaluated by focusing on intensity and duration.
Methods
Patients from the population‐based North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study, enrolled via the state cancer registry (2011–2013), were analyzed. HRQOL was measured with the Short Form 12 instrument at intervals of up to 5 years posttreatment. Smoking status was self‐reported. Linear and mixed‐effects models assessed associations with controlling for age, treatment, and time.
Results
Of 842 participants, 474 underwent prostatectomy, 258 had radiation therapy, and 110 had brachytherapy. Concurrent smoking was associated with worse general health, mental health, and physical functioning (all p < .05). Graded analysis revealed a significant dose response, with smoking ≥1 pack/day linked to the greatest declines in general health (β = −3.25; p < .001) and physical functioning (β = −2.35; p = .003) at 5 years.
Conclusions
Smoking demonstrates significant concurrent and longitudinal associations with poorer HRQOL in prostate cancer survivors, with a clear dose–response pattern. These results underscore the critical need to integrate structured smoking assessment and cessation support as a core component of comprehensive prostate cancer survivorship care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
ORCID-Profile: Ethan M Basch
Förderung
- Patient-Centered Outcomes Research Institute
- AHRQ HHS
Zitieren
APA
Borgert, B., Kay, H., Basak, R. S., Usinger, D., Matulewicz, R. S., Basch, E. M., Goldstein, A. O., Chen, R. C., & Bjurlin, M. A. (2026). Impact of smoking on health‐related quality‐of‐life outcomes in prostate cancer survivors. Cancer, 132(5). https://doi.org/10.1002/cncr.70336
Vancouver
Borgert B, Kay H, Basak RS, Usinger D, Matulewicz RS, Basch EM, et al. Impact of smoking on health‐related quality‐of‐life outcomes in prostate cancer survivors. Cancer. 2026;132(5). doi:10.1002/cncr.70336
BibTeX
@article{Borgert2026,
author = {Borgert, Benjamin and Kay, Hannah and Basak, Ram Sankar and Usinger, Deborah and Matulewicz, Richard S and Basch, Ethan M and Goldstein, Adam O and Chen, Ronald C and Bjurlin, Marc A},
title = {Impact of smoking on health‐related quality‐of‐life outcomes in prostate cancer survivors},
journal = {Cancer},
year = {2026},
volume = {132},
number = {5},
doi = {10.1002/cncr.70336}
}
EUVIMED